Atea Pharmaceuticals
AVIR
#7829
Rank
HK$1.85 B
Marketcap
HK$21.69
Share price
-3.79%
Change (1 day)
-28.04%
Change (1 year)

Atea Pharmaceuticals (AVIR) - Cash on Hand

Cash on Hand as of December 2024 : HK$3.53 Billion

According to Atea Pharmaceuticals's latest financial reports the company has HK$3.53 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Atea Pharmaceuticals - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$3.53 B-21.81%
2023-12-31HK$4.51 B-10.64%
2022-12-31HK$5.05 B-15.22%
2021-12-31HK$5.96 B-9.56%
2020-12-31HK$6.59 B3806.54%
2019-12-31HK$0.16 B-37.54%
2018-12-31HK$0.27 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
HK$1.98 B-43.71%๐Ÿ‡บ๐Ÿ‡ธ USA